About International Journal of Toxicology

The Official Journal of ACT

International Journal of Toxicology (IJT) publishes peer-reviewed, multidisciplinary articles and incisive reviews on contemporary issues in toxicology, as well as safety assessment, novel approaches to toxicological testing, mechanisms of toxicity, biomarkers, and risk assessment.

IJT serves as a forum for articles that promote basic toxicology research or facilitate and improve toxicology practice.

The journal offers six annual issues, with three supplemental issues each year devoted to contributions from the Cosmetic Ingredient Review Expert Panel. The official journal of the American College of Toxicology, IJT serves academic, industry, and regulatory toxicologists, as well as toxicology consultants.

International Journal of Toxicology is a member of the Committee on Publication Ethics (COPE).

IJT and SAGE Publishing are committed to diversity, equity, and inclusion in publishing and encourage submissions from a diverse range of authors from all countries and backgrounds.

ACT Member Access

ACT members receive full access to IJT as a member benefit. To receive an electronic alert of the IJT table of contents, sign up at SAGE Contents Alert.

Public Access

IJT articles are available via SAGE Publishing, as well as PubMed.

IJT Editorial Board

Editors
Editor-in-Chief

Mary Beth Genter, PhD, DABT, ATS | Email
University of Cincinnati, Cincinnati, OH USA

Associate Editors

Marion F. Ehrich, PhD, ATS, DABT
VA-MD College Veterinary Medicine, Blacksburg, VA USA

Donald G. Stump, PhD, DABT
Charles River, Ashland, OH USA

Book Review Editor

Robert Kapp Jr., PhD, ATS, FRSB, ERT
BioTox, Stafford Township, NJ USA

Editors Emeriti

Mildred S. Christian, PhD, Founding Editor
Robert M. Diener, DVM
Harihara M. Mehendale, PhD

Editorial Board Members
  • Krishna Allamneni, DVM, PhD, DABT
    Concarlo Therapeutics, Inc.
  • Shana Azri-Meehan, PhD, DABT
    iuvo Bioscience
  • Ted Baird, PhD
    Arcadia Preclinical Partners
  • Lisa Beilke, MSPH, PhD, DABT
    Toxicology Solutions, Inc.
  • William Brock, PhD, DABT, ATS
    Brock Scientific Consulting, LLC
  • Alan Brown, PhD, DABT
    Novartis Biomedical Research
  • Lorrene Buckley, PhD, DABT, ATS
    Eli Lilly and Company
  • John Budny, PhD
    PharmaCal, Ltd.
  • Gary Burleson, PhD
    Burleson Research Technologies
  • Florence Burleson, PhD
    Burleson Research Technologies, Inc.
  • Leigh Ann Burns Naas, PhD, DABT, ATS, ERT
    Magnolia Toxicology Consulting, LLC
  • Charleata Carter, PhD, ERT
    Carter Consulting-Zimmer Biomet Regulatory Toxicologist
  • David Compton, PhD, DABT
    AKKERI, Inc.
  • Mary Beth Genter, PhD, DABT, ATS
    University of Cincinnati
  • David Woolley, PhD, DABT, ATS, ERT, FBTS, MRSB, CBiol,
    ForthTox, Ltd.
Join Today!
Become an ACT member

and receive full access to IJT as a member benefit! We invite you to join today.

TOP